PATENT CLAIM ANALYSIS

Application Number: 16249415
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "490000"]

Abstract:
A particulate, modified release barrier coated drug-cation exchange resin complex comprising a core composed of a drug complexed with a pharmaceutically acceptable ion-exchange resin is provided. Methods of making and products containing this coated complex are described.

Claim (Index 12):
The orally ingestible aqueous liquid suspension according to  claim 9 . wherein said water permeable, water insoluble, non ionic polymeric diffusion barrier coating comprises about 30% to about 45% by weight of the drug-cation exchange resin complex.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 99.0
- Lexical Diversity: 1.21212
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15200748', '13746654', '15619637', '14065842', '15200786']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7290804070622283
- 35 USC 102 Novelty (BERT): 0.5918663074513923
- Combined Prediction Score: 0.7153589971011447
- Mean Citation Score: 489.50740800000005
- Max Citation Score: 496.6725
- Similarity Product: 441.0004244542122

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test